Daiwa Securities Group Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$11
-26.7%
4260.0%0.00%
Q2 2023$15
+36.4%
4260.0%0.00%
Q1 2023$11
-35.3%
4260.0%0.00%
Q4 2022$17
-99.9%
426
+8.1%
0.00%
Q3 2022$13,000
-7.1%
3940.0%0.00%
Q2 2022$14,0000.0%394
+29.2%
0.00%
Q1 2022$14,000
-30.0%
3050.0%0.00%
Q4 2021$20,000
-9.1%
305
-14.6%
0.00%
Q3 2021$22,000
+29.4%
357
+73.3%
0.00%
Q2 2021$17,000
+21.4%
2060.0%0.00%
Q1 2021$14,000
-6.7%
206
+6.7%
0.00%
Q4 2020$15,000
-40.0%
193
-66.8%
0.00%
Q3 2020$25,000
+56.2%
581
+2.7%
0.00%
Q2 2020$16,0000.0%5660.0%0.00%
Q1 2020$16,000
-52.9%
566
+4.8%
0.00%
Q4 2019$34,000
+100.0%
540
-9.8%
0.00%
Q3 2019$17,000
+6.2%
5990.0%0.00%
Q2 2019$16,000
+45.5%
5990.0%0.00%
Q1 2019$11,000
+83.3%
599
+25.6%
0.00%
Q4 2018$6,000
-33.3%
4770.0%0.00%
Q3 2018$9,000
+50.0%
4770.0%0.00%
Q2 2018$6,000
+100.0%
4770.0%0.00%
Q1 2018$3,0004770.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders